Nextech Biotechnology Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$14.9M
- Investors
-
7
Nextech Biotechnology General Information
Description
Manufacturer of drug delivery systems designed for pharmaceutical applications. The company offers vial reconstitution systems, ophthalmic delivery systems, vaccine delivery systems, aesthetic injection systems, pre-filled syringes, and nasal atomised devices, enabling biopharmaceutical companies to improve drug administration and packaging efficiency.
Contact Information
Website
www.nextech-x.comCorporate Office
- Rooms 302 and 104, Building 12, Number 619 Wangmei Road, Linping Street
- Linping District
- Hangzhou, Zhejiang 311100
- China
Corporate Office
- Rooms 302 and 104, Building 12, Number 619 Wangmei Road, Linping Street
- Linping District
- Hangzhou, Zhejiang 311100
- China
Nextech Biotechnology Timeline
Nextech Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series B) | 17-Sep-2026 | $14.9M | Completed | Generating Revenue | ||
| 4. Early Stage VC | 22-Oct-2025 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 22-Oct-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 05-Aug-2024 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 20-Jul-2023 | Completed | Generating Revenue |
Nextech Biotechnology Patents
Nextech Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250367077-A1 | Device and method for transferring liquid medicine from low-pressure sealed container to high-pressure sealed container | Pending | 29-May-2024 | ||
| EP-4819927-A1 | A convenient guiding needle | Pending | 06-Dec-2023 | ||
| WO-2025119201-A1 | A convenient guiding needle | Inactive | 06-Dec-2023 | ||
| US-20250041520-A1 | Injection device and method for using same | Pending | 30-May-2022 | ||
| WO-2023231304-A1 | Injection device, injection device without changing original structure of syringe, and method for using same | Inactive | 30-May-2022 | A61M5/178 |
Nextech Biotechnology Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bioinsight Ventures | Growth/Expansion | Minority | ||
| HM Capital | Venture Capital | Minority | ||
| Zhejiang Zheda Qizhen Venture Capital | University | Minority | ||
| Chinese Academy of Sciences Holdings | Government | Minority | ||
| Guoke Dongfang Fund Management | Growth/Expansion | Minority |
Nextech Biotechnology FAQs
-
When was Nextech Biotechnology founded?
Nextech Biotechnology was founded in 2021.
-
Where is Nextech Biotechnology headquartered?
Nextech Biotechnology is headquartered in Hangzhou, China.
-
What industry is Nextech Biotechnology in?
Nextech Biotechnology’s primary industry is Medical Supplies.
-
Is Nextech Biotechnology a private or public company?
Nextech Biotechnology is a Private company.
-
What is Nextech Biotechnology’s current revenue?
The current revenue for Nextech Biotechnology is .
-
How much funding has Nextech Biotechnology raised over time?
Nextech Biotechnology has raised $14.9M.
-
Who are Nextech Biotechnology’s investors?
Bioinsight Ventures, HM Capital, Zhejiang Zheda Qizhen Venture Capital, Chinese Academy of Sciences Holdings, and Guoke Dongfang Fund Management are 5 of 7 investors who have invested in Nextech Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process